MEI Pharma raised $100 M in a Post-IPO round on 2025-07-21.
According to media reports, MEI Pharma raised $100 M in a Post-IPO round on 2025-07-21.Following this round, MEI Pharma's total funding reached $100 M.
MEI Pharma, Inc.(Nasdaq: MEIP) is a clinical-stage pharmaceutical company headquartered in San Diego, California, USA, focused on developing innovative therapies that primarily combat drug resistance mechanisms in cancer, aiming to improve patient outcomes in combination with standard treatments.
This content is AI-generated.Please verify before use.
Disclaimer: The Crypto Calendar is for informational purposes only and doesn’t reflect Gate.com’s views or serve as financial advice.
Comment
Fundraising History
| Round | Amount | Valuation | Time | Investor(s) |
|---|---|---|---|---|
| Post-IPO | $100 M | -- | 2025-07-21 | -- |
Key Milestones
- 2025-07-22MEI Pharma completes a $100 million private placement in financing
- GT-1.78%
- BTC-2.73%
- ETH-3.72%